Journal article · 2025 · Open access

Antibody/ siRNA Nanocarriers Against Wnt Signaling Suppress Oncogenic and Stem‐Like Behavior in Triple‐Negative Breast Cancer Cells

Elise C. Hoover, Emily S. Day

Journal of Biomedical Materials Research Part A, 113(1), e37867 · Published 1 January 2025 · DOI 10.1002/jbm.a.37867

Open PDFView at the publisherCite this paper

In brief

“Antibody/ siRNA Nanocarriers Against Wnt Signaling Suppress Oncogenic and Stem‐Like Behavior in Triple‐Negative Breast Cancer Cells” is a 2025 journal article by Elise C. Hoover and Emily S. Day, published in Journal of Biomedical Materials Research Part A. OpenAlex counts 4 citations as of 21 November 2026. It is open access: the full text is free to read at Journal of Biomedical Materials Research Part A.

Citations
4
Most cited in
2026 (3)
Field-weighted impact
0.62
References
66
Authors
2

Abstract

Triple-negative breast cancer (TNBC) is infamous for its aggressive phenotype and poorer prognosis when compared to other breast cancer subtypes. One factor contributing to this poor prognosis is that TNBC lacks expression of the receptors that available hormonal or molecular-oriented therapies attack. New treatments that exploit biological targets specific to TNBC are desperately needed to improve patient outcomes. One promising target for therapeutic manipulation is the Wnt signaling pathway, which has been associated with many invasive breast cancers, including TNBC. This pathway is activated in TNBC cells when extracellular Wnt ligands bind to overexpressed Frizzled7 (FZD7) transmembrane receptors, leading to downstream activation of intracellular β-catenin proteins. To target and inhibit Wnt signaling in TNBC cells, polymer nanoparticles (NPs) modified with anti-FZD7 antibodies and β-catenin small interfering RNAs (siRNAs) were developed, and their impact on the oncogenic behavior of treated TNBC cells was investigated. When compared to control NPs, the Wnt-targeted NPs induced greater levels of Wnt oncogene suppression. This led to greater inhibition of oncogenic and stem-like properties, including cell proliferation, drug resistance, and spheroid formation capacity. This work demonstrates a promising approach for targeting the Wnt pathway in TNBC to counter the cellular phenotypes that drive disease progression.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Hoover, E. C., & Day, E. S. (2025). Antibody/ siRNA Nanocarriers Against Wnt Signaling Suppress Oncogenic and Stem‐Like Behavior in Triple‐Negative Breast Cancer Cells. Journal of Biomedical Materials Research Part A, 113(1), e37867. https://doi.org/10.1002/jbm.a.37867

MLA 9

Hoover, Elise C., and Emily S. Day. “Antibody/ siRNA Nanocarriers Against Wnt Signaling Suppress Oncogenic and Stem‐Like Behavior in Triple‐Negative Breast Cancer Cells.” Journal of Biomedical Materials Research Part A, vol. 113, no. 1, 2025, p. e37867. https://doi.org/10.1002/jbm.a.37867.

Chicago

Hoover, Elise C. and Emily S. Day. 2025. “Antibody/ siRNA Nanocarriers Against Wnt Signaling Suppress Oncogenic and Stem‐Like Behavior in Triple‐Negative Breast Cancer Cells.” Journal of Biomedical Materials Research Part A 113 (1): e37867. https://doi.org/10.1002/jbm.a.37867.

Harvard

Hoover, E. C. and Day, E. S. (2025) ‘Antibody/ siRNA Nanocarriers Against Wnt Signaling Suppress Oncogenic and Stem‐Like Behavior in Triple‐Negative Breast Cancer Cells’, Journal of Biomedical Materials Research Part A, 113(1), p. e37867. doi:10.1002/jbm.a.37867.

IEEE

E. C. Hoover and E. S. Day, “Antibody/ siRNA Nanocarriers Against Wnt Signaling Suppress Oncogenic and Stem‐Like Behavior in Triple‐Negative Breast Cancer Cells,” Journal of Biomedical Materials Research Part A, vol. 113, no. 1, p. e37867, 2025, doi: 10.1002/jbm.a.37867.

BibTeX

@article{hoover2025antibody,
  title     = {{Antibody/ siRNA Nanocarriers Against Wnt Signaling Suppress Oncogenic and Stem‐Like Behavior in Triple‐Negative Breast Cancer Cells}},
  author    = {Hoover, Elise C. and Day, Emily S.},
  journal   = {Journal of Biomedical Materials Research Part A},
  year      = {2025},
  volume    = {113},
  number    = {1},
  pages     = {e37867},
  doi       = {10.1002/jbm.a.37867},
  url       = {https://doi.org/10.1002/jbm.a.37867}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery

  • triple-negative breast cancer
  • Wnt signaling
  • β-catenin
  • siRNA delivery
  • nanocarriers
  • cancer stemness
  • drug resistance
  • cell proliferation

Work with this paper

Most-cited papers in Materials Science

All highly cited Materials Science papers

Questions about this paper

How do I cite this paper in APA style?

Hoover, E. C., & Day, E. S. (2025). Antibody/ siRNA Nanocarriers Against Wnt Signaling Suppress Oncogenic and Stem‐Like Behavior in Triple‐Negative Breast Cancer Cells. Journal of Biomedical Materials Research Part A, 113(1), e37867. https://doi.org/10.1002/jbm.a.37867

How many times has this paper been cited?

4 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Journal of Biomedical Materials Research Part A: sign in and open the PDF from this page.

Who wrote this paper?

Elise C. Hoover, Emily S. Day.

What is the DOI of this paper?

10.1002/jbm.a.37867, permanently at https://doi.org/10.1002/jbm.a.37867. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.